清野宗一郎

研究者氏名	清野宗一郎
	きよのそういちろう
通称等の別名	Soichiro Kiyono
URL
所属	千葉大学
部署	医学部附属病院消化器内科
職名	特任助教
学位	医学博士
J-Global ID	202201002641706403

論文

<3 456 7 >

Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma.

Naoto Fujita Naoya Kanogawa Hirokazu Makishima Sadahisa Ogasawara Susumu Maruta Yotaro Iino Yuki Shiko Hiroaki Kanzaki Keisuke Koroki Kazufumi Kobayashi Soichiro Kiyono Masato Nakamura Takayuki Kondo Shingo Nakamoto Tetsuhiro Chiba Masaru Wakatsuki Ei Itobayashi Masamichi Obu Yoshihiro Koma Ryosaku Azemoto Yohei Kawasaki Jun Kato Hiroshi Tsuji Naoya Kato

Hepatology research : the official journal of the Japan Society of Hepatology 52(12) 1060-1071 2022年8月

AIM: Carbon-ion radiotherapy (C-ion RT) has shown potential as a curative treatment for patients with hepatocellular carcinoma (HCC). However, no reports have compared the effectiveness of C-ion RT and radiofrequency ablation (RFA). This study aim...

Changes in therapeutic options for hepatocellular carcinoma in Asia.

Sadahisa Ogasawara Keisuke Koroki Hiroaki Kanzaki Kazufumi Kobayashi Soichiro Kiyono Masato Nakamura Naoya Kanogawa Tomoko Saito Takayuki Kondo Ryo Nakagawa Shingo Nakamoto Ryosuke Muroyama Tetsuhiro Chiba Naoya Kato

Liver international : official journal of the International Association for the Study of the Liver 42(9) 2055-2066 2022年8月

The incidence rate of hepatocellular carcinoma (HCC) is expected to increase, with most cases occurring in Asia. In some parts of Asia, the occurrence of HCC developing from metabolic-related liver disease has markedly increased in recent years, w...

A diet-induced murine model for non-alcoholic fatty liver disease with obesity and insulin resistance that rapidly develops steatohepatitis and fibrosis.

Takafumi Sakuma Masato Nakamura Tetsuhiro Chiba Terunao Iwanaga Motoyasu Kan Ryuta Kojima Junjie Ao Yaojia Ma Hidemi Unozawa Naoto Fujita Kengo Kanayama Hiroaki Kanzaki Keisuke Koroki Kazufumi Kobayashi Ryo Nakagawa Naoya Kanogawa Soichiro Kiyono Takayuki Kondo Tomoko Saito Sadahisa Ogasawara Shingo Nakamoto Ryosuke Muroyama Jun Kato Takashi Kishimoto Naoya Kato

Laboratory investigation; a journal of technical methods and pathology 102(10) 1150-1157 2022年5月

Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver disease worldwide. Patients with NAFLD often suffer steatohepatitis, which can progress to cirrhosis and hepatocellular carcinoma. The presence of visceral obe...

Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial.

Sadahisa Ogasawara Keisuke Koroki Hirokazu Makishima Masaru Wakatsuki Asahi Takahashi Sae Yumita Miyuki Nakagawa Takamasa Ishino Keita Ogawa Kisako Fujiwara Terunao Iwanaga Takafumi Sakuma Naoto Fujita Ryuta Kojima Hiroaki Kanzaki Kazufumi Kobayashi Soichiro Kiyono Masato Nakamura Naoya Kanogawa Tomoko Saito Takayuki Kondo Ryo Nakagawa Shingo Nakamoto Ryosuke Muroyama Tetsuhiro Chiba Yoshihito Ozawa Yohei Kawasaki Tomoya Kurokawa Hideki Hanaoka Hiroshi Tsuji Naoya Kato

BMJ open 12(4) e059779 2022年4月

INTRODUCTION: Advanced hepatocellular carcinoma (HCC) with macrovascular invasion (MVI) has the worst prognosis among all phenotypes. This trial aims to evaluate whether treatment with durvalumab, alone or in combination with tremelimumab, plus pa...

長期経過で自然消退と再燃を繰り返した肝肉芽腫の1例

桑野美智子近藤孝行山本修一遠藤八千代池田祐一今泉優理小林和史清野宗一郎岸本充加藤直也

超音波医学 49(Suppl.) S837-S837 2022年4月